3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Orphanet Journal of Rare Diseases, 15, S. 48-
- Ereignis
-
Veröffentlichung
- (wo)
-
Sankt Augustin
- (wer)
-
Hochschule Bonn-Rhein-Sieg
- (wann)
-
2020
- Urheber
- DOI
-
10.1186/s13023-020-1319-7
- URN
-
urn:nbn:de:hbz:1044-opus-47684
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Grünert, Sarah
- Sass, Jörn Oliver
- Hochschule Bonn-Rhein-Sieg
Entstanden
- 2020
Ähnliche Objekte (12)
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Correction to: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings
Isovalerianazidämie : Klinik, Pathobiochemie und Therapie am Beispiel von 28 Patienten
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: data from an international questionnaire
Neurological outcome in long‐chain hydroxy fatty acid oxidation disorders
3-hydroxy-3-methylglutaryl-coenzyme a lyase deficiency: a case report
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Correction to: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings
Isovalerianazidämie : Klinik, Pathobiochemie und Therapie am Beispiel von 28 Patienten
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: data from an international questionnaire
Neurological outcome in long‐chain hydroxy fatty acid oxidation disorders
3-hydroxy-3-methylglutaryl-coenzyme a lyase deficiency: a case report
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Correction to: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings
Isovalerianazidämie : Klinik, Pathobiochemie und Therapie am Beispiel von 28 Patienten
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: data from an international questionnaire
Neurological outcome in long‐chain hydroxy fatty acid oxidation disorders